PHILADELPHIA, July 30, 2024 /PRNewswire/ -- uMethod Health, a pioneer in personalized cognitive care planning, has announced that it is collaborating with Linus Health, a digital health company enabling early detection of cognitive impairment, Alzheimer's and other dementias, to create a more efficient and effective approach to brain health. The collaboration provides clinicians with an integrated solution for earlier detection of cognitive impairment plus care planning. With the increasing prevalence of cognitive impairment, including…READ MORE

Nearly half (48.1%) of American adults have high blood pressure (HBP, or hypertension). However, many are unaware of the problem, which often causes no symptoms. This situation is very dangerous. HBP damages the heart and blood vessels and causes strokes. It’s a leading cause of kidney failure. Hypertension is even a major risk factor for Alzheimer's disease and related dementias (ADRD). The combination of HBP and sleep apnea is particularly…READ MORE

Cognitive decline is multi-factorial but rarely treated as such due to clinical complexity of the process. Emerging data driven systems with assistive-AI enable physicians to deliver comprehensive and personalized care at scale. Vik's session introduces uMETHOD's RestoreU solution, a software based service which is helping transform care of cognitive decline and its costs to society. The solution is available nationwide through several diagnostic lab service providers. To view Vik's discussion…READ MORE

The US Senate passed the Promise to Address Comprehensive Toxics (PACT) Act on August 2, 2022. The PACT healthcare bill is a positive step toward assisting the 3.5 million veterans affected by exposure to toxins during military service. The debate surrounding the PACT legislation drew attention to a stark fact: too many of America’s veterans live with ill health. In 2020, the Veterans Administration National Center for PTSD conducted a…READ MORE

RESEARCH TRIANGLE PARK – Triangle Tweener Fund continues to provide fuel for the region’s startup ecosystem, cranking out 18 investments and adding 14 additional companies to its portfolio in the last three months. “This is up 20% year over year deal wise and 30% investment wise,” says Tweener fund founder and serial entrepreneur Scot Wingo. The fund was established last year and targets startups headquartered in the Research Triangle Park. So far…READ MORE

The quality of the food we eat can have profound effects on our health. Researchers have identified many links between the consumption of Western-style diets and several chronic diseases: type 2 diabetes, cardiovascular disease, several types of cancer, and Alzheimer's Disease and Related Dementias (ADRD). Someone with these eating habits tends to consume too much fast food, highly processed (or “junk”) foods, and sugary drinks, and does not eat enough…READ MORE

RESEARCH TRIANGLE PARK –  Alzheimer’s Disease and dementia have long been feared by many, especially those with first-hand experience. Vik Chandra, CEO and co-founder of uMETHOD is familiar with this disease having seen it in both his grandmother and mother-in-law. According to Chandra, there are 17 and a half million Medicare-aged patients somewhere on a spectrum of cognitive decline, and about 150,000 doctors across the country caring for these patients. He is passionate…READ MORE

Secaucus, NJ and Raleigh, NC – May 4, 2023 – Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced nationwide availability of the RestoreU™ Dementia Panel, a risk assessment and care plan service created by uMETHOD Health, a health technology company specializing in precision medicine for chronic diseases, to help physicians close care gaps for patients with cognitive decline. The RestoreU service employs artificial intelligence…READ MORE

Quest Diagnostics and uMETHOD Health, Inc. are excited to announce the national launch of a robust solution in the fight against dementia. Using a 3-step approach that combines our advanced testing with uMETHOD’s AI-based technology, you can help patients prevent cognitive decline, improve brain health, and maintain independence. Learn more about Quest Diagnostic's Alzheimer's disease testing portfolio at Questforthecure.com or contact a uMETHOD Health representative today.…READ MORE

World Kidney Day has been observed in early March since 2006;  in the US, March is National Kidney Month. Efforts to increase awareness of kidney health are timely, as chronic kidney disease (CKD) affected an estimated 37 million Americans in 2021. Drugs prescribed for common illnesses can increase the risk or severity of CKD. This risk comes in addition to drug-to-drug interactions (DDIs) that might also exacerbate CKD. And unfortunately,…READ MORE